Rx&D announces the creation of the Paul Lucas Scholarship for the Faculty of Health Sciences at Queen's University

TORONTO, Nov. 14, 2012 /CNW/ - Canada's Research-Based Pharmaceutical Companies (Rx&D) President Russell Williams announced the creation of a Queen's University scholarship today, during the association's Annual General Meeting (AGM). The $50,000 scholarship recognizes a past Chair of the Rx&D Board and will support a student studying health sciences at Queen's University.

"Partnerships between academic medical centres and industries have always been of utmost importance to realize fully the benefits of bio-medical research and ensure continued advances in the prevention, diagnosis and treatment of disease," said Mr. Williams during the AGM, which brought industry and stakeholders together to explore ways in which to better collaborate to realize improved health outcomes for Canadians within a more sustainable health care environment.

The Paul Lucas Scholarship for the Faculty of Health Sciences has been created in honour of Mr. Paul Lucas, past Chair of the Board of Rx&D and retired CEO of GlaxoSmithKline Inc. Rx&D has contributed $25,000 to the scholarship, and this commitment has been matched by Mr. Paul Lucas and his wife Mrs. Linda Lucas for a total of $50,000. The scholarship will be awarded to a student of the Faculty of Health Sciences at Queen's University.

"I want to thank Rx&D for creating this scholarship in my name. It has been an honour to represent the pharmaceutical industry over the years, and Linda and I are pleased to be able to support Queen's with this gift," added Mr. Lucas.

About Rx&D
Rx&D is the association of leading research-based pharmaceutical companies dedicated to improving the health of Canadians through the discovery and development of new medicines and vaccines. Our community invests more than $1 billion in research and development each year to fuel Canada's knowledge-based economy. Guided by our Code of Ethical Practices, our membership is committed to working in partnership with governments, healthcare professionals and stakeholders in a highly ethical manner.

SOURCE: CANADA'S RESEARCH-BASED PHARMACEUTICAL COMPANIES (RX&D)

Isabelle Robillard
Media Relations
Telephone: [phone] (extension 831)
E-mail: [email protected]